Blog Archives
A global effort to improve childhood cancer treatment
13/07/2018
A database of genetic information of more than 270 cancer models, encompassing 25 different childhood cancers, has just been made publicly available. Children’s Cancer Institute contributed 90 leukaemia models to this global effort.
$1 million funding boost for Zero Childhood Cancer program
11/05/2018
NSW Health Minister Brad Hazzard has announced a $1 million funding boost for the Zero Childhood Cancer program. The money will support an immunotherapy trial for children with brain cancer.
Sydney Airport Community helps neuroblastoma research take off
01/03/2018
Money raised by the Sydney Airport Community Christmas Giving Appeal will support an innovative project to find better treatments for neuroblastoma.
A very techie Christmas
28/11/2017
We’ve already started opening our presents. Christmas has come early as new technologies take their place in our labs, promising to speed up childhood cancer research.
Resistance is futile: The MRP1 story
18/10/2017
How we got to now in our understanding of MRP1, a protein that ejects chemotherapy drugs from tumour cells and stops them stopping cancer. We're exploring future drugs that target it.
Emerging researchers: Dan Carter, project leader
14/06/2017
In the final post in our three-part series about emerging researchers, Dr Dan Carter talks about making discoveries that contribute towards a cure.
Changing the future for children with brain cancer
02/06/2017
Brain tumours are among the deadliest childhood cancers and Diffuse Intrinsic Pontine Glioma (DIPG) one of the most aggressive. But we’re making progress in the search for effective treatments.
Kicking goals for brain cancer research
02/03/2017
An award for our brain cancer team recognises research into one of the nastiest childhood cancers. Our team will test potential new treatments on tiny soccer balls of cells.
Neuroblastoma treatment search: polyamine puzzles and beyond
23/02/2017
We're starving neuroblastoma of polyamines with drug DFMO. But there won't be just one cure for such a diverse disease.
$6.6M for much-needed neuroblastoma research
09/02/2017
Better targeted therapies for neuroblastoma are desperately needed. They’re now a step closer.
